-
Epidemiological Burden of Osteoarthritis in Eastern, Central, and Western Europe Between 1990 and 2021
Sep 9, 2025, 16:22 PM -
Economic Evaluation of Neoadjuvant Talimogene Laherparepvec Plus Surgery for Resectable Stage IIIB-IV M1a Melanoma
Sep 9, 2025, 16:22 PM -
Prognostic Factor Evaluation for Clinical Outcomes in HER2-Mutant NSCLC
Sep 9, 2025, 16:22 PM -
Systematic Literature Review of Artificial Intelligence-Based Models Predicting COPD Exacerbations
Sep 9, 2025, 16:22 PM -
Simulation of the Impact on LDLC Targets and Treatment Cost in High and Very High Cardiovascular Risk Patients of Cost-Based Sequencing of Lipid-Lowering Therapy
Sep 9, 2025, 16:22 PM -
A Review of Health Economic Modeling Challenges for Opioid Use Disorder Treatment in Prison Settings
Sep 9, 2025, 16:22 PM -
Use of Innovative Methods in Long-Term Follow-up Observational Studies: An AI-Enabled Targeted Literature Review
Sep 9, 2025, 16:22 PM -
What Is the Cost of Preventing Tuberculosis a Cost-Effectiveness Analysis of Household Contact Tracing With 3HP Preventive Therapy in High-Burden Areas of Nepal?
Sep 9, 2025, 16:22 PM -
Let LAMBA Do the Work: Can We Reduce Reliance on VBA in Health Economic Models?
Sep 9, 2025, 16:22 PM -
Bridging the Gap: How Early Access Shapes Pricing and Reimbursed Populations in France
Sep 9, 2025, 16:22 PM -
Methodological Challenges for the Economic Evaluation of Genomic Newborn Screening: A Scoping Review
Sep 9, 2025, 16:22 PM -
Review of Patient Decision Aids for Psoriasis
Sep 9, 2025, 16:22 PM -
Economic Evaluation of Tarlatamab as Second-Line Therapy for Metastatic Small-Cell Lung Cancer: A United States Perspective
Sep 9, 2025, 16:22 PM -
Strengths and Limitations of AI-Assisted Abstract Screening to Identify Patient-Reported Outcome Instruments: A Comparison of Two AI-Assisted Platforms and Traditional Methods
Sep 9, 2025, 16:22 PM -
Incorporating Equity-of-Access Into Health Economic Evaluations: Surgical Task-Shifting for C-Sections in Sierra Leone
Sep 9, 2025, 16:22 PM -
Economic Evaluations of Medication Safety Interventions in Primary Care: A Systematic Literature Review
Sep 9, 2025, 16:22 PM -
The Therapeutic Value of Bispecific Antibodies in Hematology: Analysis of Health Technology Assessments From Three European Countries
Sep 9, 2025, 16:22 PM -
Cost Management Gaps and Economic Waste in Colombia’s Health Insurance System: A Strategic Need for Costing and Microcosting Methodologies
Sep 9, 2025, 16:22 PM -
Direct Medical Costs of Home-Based Respiratory Support and Oxygen Therapy for Patients With Chronic Respiratory Failure
Sep 9, 2025, 16:22 PM -
Exit Strategies in Patients With Stable MS: Cost-Effectiveness of Extended Interval Dosing of Ocrelizumab and Natalizumab vs. De-escalating to Cladribine
Sep 9, 2025, 16:22 PM